1. Academic Validation
  2. Synthesis of flutamide-conjugates

Synthesis of flutamide-conjugates

  • Bioorg Med Chem Lett. 2020 Nov 1;30(21):127507. doi: 10.1016/j.bmcl.2020.127507.
Julio César Medina-Rojas 1 Irving Osiel Castillo-Rodríguez 1 Elena Martínez-Klimova 2 Teresa Ramírez-Ápan 1 Simón Hernández-Ortega 1 Marcos Martínez-García 3
Affiliations

Affiliations

  • 1 Instituto de Química, Universidad Nacional Autónoma de México, Ciudad Universitaria, Circuito Exterior, Coyoacán, C.P. 04510, México, D.F., México.
  • 2 Facultad de Química, Universidad Nacional Autónoma de México, Ciudad Universitaria, Circuito Interior, Coyoacán, C.P. 04510, México, D.F., México.
  • 3 Instituto de Química, Universidad Nacional Autónoma de México, Ciudad Universitaria, Circuito Exterior, Coyoacán, C.P. 04510, México, D.F., México. Electronic address: margar@unam.mx.
Abstract

In this paper, we designed and extended modification basing on the flutamide structure. A series of flutamide-conjugates were obtained with methyl bromoacetate and ethylenediamine. Through the synthesis of two conjugates with 3,5-bis(dodecyloxy)benzoate derivatives, these flutamide conjugates were tested for Anticancer activity. Among the compounds tested, the flutamide-conjugates showed good inhibition activity against Cancer cell lines U-251, PC-3 and K-562. The conjugates showed a better inhibitory effect than free flutamide and did not show activity against normal COS-7 monkey kidney fibroblast cells. It was also observed that the flutamide conjugates had an inhibitory effect against human colorectal adenocarcinoma HCT-15.

Keywords

Antiproliferative; Cancer; Flutamide conjugates; PC-3 inhibitors; Therapy.

Figures